ADMA: an emerging cardiovascular risk factor
نویسندگان
چکیده
منابع مشابه
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
The concurrence of visceral obesity, insulin resistance and dyslipidaemia comprises the concept of the metabolic syndrome. The metabolic syndrome is an escalating problem in developed and developing societies that tracks with the obesity epidemic. Dyslipidaemia in the metabolic syndrome is potently atherogenic and, hence, is a major risk factor for CVD (cardiovascular disease) in these subjects...
متن کامل[Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study].
INTRODUCTION AND OBJECTIVES Emerging cardiovascular (CV) risk factors such as adiponectin, glycosilated hemoglobin, waist circumference and the high-sensitivity C-reactive protein (hsCRP) level can aid CV risk stratification. It has been shown that classic factors alone are not sufficient to explain CV risk fully. The adiponectin level has been linked to insulin resistance, dyslipidemia and cor...
متن کاملLipoprotein(a): an emerging cardiovascular risk factor in hypertensive patients
Background: Several novel criteria can improve detection of subclinical atherosclerosis. In particular, the clinical interest has focused on lipoprotein(a), a modified LDL particle which presents a structurally homologue protein to plasminogen. Aim: The aim of our work was to evaluate the levels of lipoprotein(a), in hypertensive patients with or without atherogenic dyslipidemia comparative wit...
متن کاملChlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
Recent appreciation of atherosclerosis as a chronic, inflammatory disease has rekindled efforts to examine the role that infectious agents may play in atherogenesis. In particular, much interest has focused on infection with Chlamydia pneumoniae. The possibility that a prokaryote contributes to atherogenesis has high clinical interest, as C pneumoniae infection may be a treatable risk factor. T...
متن کامل[Cocaine as a possible emerging cardiovascular risk factor].
1. di Marco J, Sellers T, Lerman B, Greenberg M, Berne R, Bellardinelli L. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol 1985;6: 417-25. 2. Strickberger SA, Man C, Daoud EG, Goyal R, Brinkman K, Knight BP, et al. Adenosine-induced atrial arrhythmia: a prospective analysis. Ann Intern Med 1997;127:417-22. 3. Silverman RT, Machad...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vascular Medicine
سال: 2005
ISSN: 1358-863X,1477-0377
DOI: 10.1177/1358836x0501000101